Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide μ (mu) and plasmid DNA

Gene Therapy

Volumn 9, Issue 9, 2002, Pages 564-576

  Tagawa, T ^a   Manvell, M ^b   Brown, N ^b   Keller, M ^a   Perouzel, E ^a   Murray, K D ^a   Harbottle, R P ^b   Tecle, M ^a   Booy, F ^a   Brahimi Horn, M C ^c   Coutelle, C ^b   Lemoine, N R ^b   Miller, A D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c INSERM   (France)

Author keywords

Adenovirus; Cationic lipids; Cationic liposomes; mu peptide; Non viral gene therapy

Indexed keywords

BUFFER; CATION; CORE PROTEIN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; FLUORESCENT DYE; LIPOSOME; MACROGOL; MACROGOL 5000; NANOPARTICLE; NUCLEIC ACID; NUCLEOTIDE; PLASMID DNA; REAGENT; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN MU;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BODY FLUID; CELL NUCLEUS MEMBRANE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRYOPRESERVATION; DNA TRANSFECTION; DRUG FORMULATION; DRUG STORAGE; ENCAPSULATION; ENDOCYTOSIS; FLUORESCENCE; GENE DOSAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; RAT; REPRODUCIBILITY;

3T3 CELLS; ADENOVIRIDAE; ANIMALS; COS CELLS; GENE THERAPY; GENETIC ENGINEERING; HUMANS; LIPOSOMES; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; NANOTECHNOLOGY; PLASMIDS; RATS; TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL CORE PROTEINS;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES;

EID: 0036265251     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301686     Document Type: Article

References (62)

1. Cationic liposomes for gene therapy
2. Nonviral delivery systems for gene therapy
3. Noninvasive liposome-mediated gene delivery can correct the ion-transport defect in cystic-fibrosis mutant mice
4. Polyamine analogues of 3-β-[N-(N'N'-dimethylaminoethane)carbomoyl]cholesterol (DC-Chol) as agents for gene delivery
5. Cationic lipids for gene therapy. Part 4 Physicochemical analysis of cationic liposome-DNA complexes (lipoplexes) with respect to in vitro and in vivo gene delivery efficiency
6. Protamine sulfate provides enhanced and reproducible intravenous gene transfer by cationic liposome/DNA complex
7. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes
8. Protamine sulfate enhances lipid-mediated gene transfer
9. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery
10. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: Implications for intravenous lipofection
11. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes
12. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth
13. Structure and function of lipid-DNA complexes for gene delivery
14. High-efficiency gene transfection of macrophages by lipoplexes
15. Physical stability and in vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes
16. Potentiation of cationic liposome-mediated gene delivery by polycations
17. Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells
18. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery
19. DNA transfection mediated by cationic liposomes containing lipopolylysine. Characterization and mechanism of action
20. Gene transfer into mammalian cells using histone-condensed plasmid DNA
21. Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation
22. Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: Cationic liposomal gene therapy of carcinomatosa
23. Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo
24. An integrin-targeted non-viral vector for pulmonary gene therapy
25. Peptide mini-vectors for gene delivery
26. Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells
27. Transfection using synthetic peptides: Comparison of three DNA-compacting peptides and effect of centrifugation
28. Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes
29. Characterization of the adenovirus-2 virion protein Mu
30. Isolation and characterisation of an extremely basic protein from adenovirus type 5
31. Interactions among the 3 adenovirus core proteins
32. Adenovirus core protein V is delivered by the invading virus to the nucleus of the infected cell and later in infection is associated with nucleoli
33. Adenovirus core protein V interacts with p32. A protein which is associated with both the mitochondria and the nucleus
34. Biophysical characterization of the DNA binding and condensing properties of adenoviral core peptide μ (mu)
35. Enhanced cationic liposome-mediated transfection using the DNA-binding peptide μ (mu) from the adenovirus core
36. Stabilized plasmid-lipid particles for regional gene therapy: Formulation and transfection properties
37. Optimization of liposome mediated transfection of a neuronal cell line
38. Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery
39. Nondegradative in vitro labeling of plasmid DNA
40. Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon
41. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung
42. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial
43. Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy
44. Overcoming barriers to nonviral gene delivery
45. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides
46. Progress towards a synthetic virus for systemic gene therapy
47. Endosomes lysosomes: Their implication in gene transfer
48. Effects of component cholesterol on the structure of lipid monolayer and bilayer membranes
49. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors
50. Aphidicolin: A specific inhibitor of nuclear-DNA replication in eukaryotes
51. Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy
52. Nuclear targeting peptide scaffolds for lipofection of non-dividing mammalian cells
53. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus
54. Uptake of exogenous DNA via the skin
55. Intracellular fate and nuclear targeting of plasmid DNA
56. Mitosis enhances transgene expression of plasmid delivered by cationic liposomes
57. Solid-phase synthesis
58. Access to the inaccessible sequence of Cpn 60.1 (195-217) by temporary oxazolidine protection of selected amide bonds
59. Colorimetric determination of phospholipids with ammonium ferrothiocyanate
60. Characterization of human tracheal epithelial cells transformed by an origin-defective Simian virus-40
61. Cell delivery intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells